BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4070930)

  • 21. Comparability of results of postnatal and long-term tests for carcinogenicity.
    Sýkora I; Vortel V
    Neoplasma; 1993; 40(5):321-7. PubMed ID: 8272162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutagenicity, carcinogenicity and teratogenicity of aluminium.
    Léonard A; Gerber GB
    Mutat Res; 1988 Nov; 196(3):247-57. PubMed ID: 3059176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenic activity of chemicals previously tested for carcinogenicity in the National Cancer Institute bioassay program.
    Dunkel VC; Simmon VF
    IARC Sci Publ; 1980; (27):283-301. PubMed ID: 7002779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the carcinogenic risk of environmental chemicals].
    Ito N; Imaida K; Ogiso T; Tamano S; Kurata Y
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3345-53. PubMed ID: 3789750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary modulation of the carcinogenicity of the heterocyclic amines.
    Weisburger JH; Rivenson A; Kingston DG; Wilkins TD; Van Tassell RL; Nagao M; Sugimura T; Hara Y
    Princess Takamatsu Symp; 1995; 23():240-50. PubMed ID: 8844815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate.
    Gocke E; Bürgin H; Müller L; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):254-65. PubMed ID: 19857796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternatives to the 2-species bioassay for the identification of potential human carcinogens.
    Ashby J
    Hum Exp Toxicol; 1996 Mar; 15(3):183-202. PubMed ID: 8839204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of functional group substitutions on the carcinogenicity of anthraquinone in rats and mice: analysis of long-term bioassays by the National Cancer Institute and the National Toxicology Program.
    Doi AM; Irwin RD; Bucher JR
    J Toxicol Environ Health B Crit Rev; 2005; 8(2):109-26. PubMed ID: 15804751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenicity, carcinogenicity and teratogenicity of zinc.
    Léonard A; Gerber GB; Léonard F
    Mutat Res; 1986 Nov; 168(3):343-53. PubMed ID: 3540646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioassays for carcinogenicity in animals. Assays for initiating and promoting activities.
    Bannasch P; Griesemer RA; Anders F; Becker R; Cabral JR; Della Porta G; Feron VJ; Henschler D; Ito N; Kroes R
    IARC Sci Publ; 1986; (83):103-26. PubMed ID: 3305339
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of pesticides which pose carcinogenicity potential in animal testing. I. Developing a tumor data evaluation system.
    Wang GM
    Regul Toxicol Pharmacol; 1984 Dec; 4(4):355-60. PubMed ID: 6522666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Testing of the carcinogenicity and teratogenicity of the Bulgarian tissue adhesive kanokonlit-B].
    Stoĭchev I; Pŭrvanova L; Stoianov I; Chernozemski I
    Khirurgiia (Sofiia); 1984; 37(3):194-9. PubMed ID: 6540828
    [No Abstract]   [Full Text] [Related]  

  • 35. [Teratogenic and mutagenic studies with caffeine in the animal experiment].
    von Kreybig T; Czok G
    Z Ernahrungswiss; 1976 Mar; 15(1):64-70. PubMed ID: 960793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of human cancer risk: challenges for alternative approaches.
    Omenn GS
    Toxicol Pathol; 2001; 29 Suppl():5-12. PubMed ID: 11695561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment.
    Gulezian D; Jacobson-Kram D; McCullough CB; Olson H; Recio L; Robinson D; Storer R; Tennant R; Ward JM; Neumann DA
    Toxicol Pathol; 2000; 28(3):482-99. PubMed ID: 10862569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of risk from exposure to acrylonitrile: the general approach used by a consultant.
    Page NP; Cook B
    Sci Total Environ; 1990 Dec; 99(3):307-16; discussion 316-7. PubMed ID: 2077662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
    O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
    Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The carcinogenicity of anticancer drugs: a hazard in man.
    Harris CC
    Cancer; 1976 Feb; 37(2 Suppl):1014-23. PubMed ID: 766951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.